-
FEBRASGO POSITION STATEMENT
Operative vaginal delivery: Number 7 – July 2023
Revista Brasileira de Ginecologia e Obstetrícia. 2023;45(7):422-434
09-08-2023
Summary
FEBRASGO POSITION STATEMENTOperative vaginal delivery: Number 7 – July 2023
Revista Brasileira de Ginecologia e Obstetrícia. 2023;45(7):422-434
09-08-2023 -
FEBRASGO POSITION STATEMENT
Cervical cancer in pregnancy
Revista Brasileira de Ginecologia e Obstetrícia. 2023;45(5):293-296
08-07-2023
Summary
FEBRASGO POSITION STATEMENTCervical cancer in pregnancy
Revista Brasileira de Ginecologia e Obstetrícia. 2023;45(5):293-296
08-07-2023 -
FEBRASGO POSITION STATEMENT
Misoprostol use in obstetrics: Number 6 – June 2023
Revista Brasileira de Ginecologia e Obstetrícia. 2023;45(6):356-367
08-04-2023
Summary
FEBRASGO POSITION STATEMENTMisoprostol use in obstetrics: Number 6 – June 2023
Revista Brasileira de Ginecologia e Obstetrícia. 2023;45(6):356-367
08-04-2023 -
FEBRASGO POSITION STATEMENT
Guidelines on how to monitor gestational weight gain during antenatal care: Number 2 – February 2023
Revista Brasileira de Ginecologia e Obstetrícia. 2023;45(2):104-108
07-10-2023
Summary
FEBRASGO POSITION STATEMENTGuidelines on how to monitor gestational weight gain during antenatal care: Number 2 – February 2023
Revista Brasileira de Ginecologia e Obstetrícia. 2023;45(2):104-108
07-10-2023 -
FEBRASGO POSITION STATEMENT
Fertility preservation in gynecologic cancer patients
Revista Brasileira de Ginecologia e Obstetrícia. 2023;45(3):161-167
07-10-2023
Summary
FEBRASGO POSITION STATEMENTFertility preservation in gynecologic cancer patients
Revista Brasileira de Ginecologia e Obstetrícia. 2023;45(3):161-167
07-10-2023Views163Background Gynecological cancer directly affects fertility, as treatment consists of surgical removal of the reproductive system and/or exposure to gonadotoxic agents. However, patients in early stages who meet established criteria can be treated with fertility-sparing surgeries and reach equivalent oncological results to those of traditional treatments. Fertility preservation techniques such as cryopreservation of oocytes, embryos […]See more -
FEBRASGO POSITION STATEMENT
Accurate diagnosis of breast lesions Number 4 – April 2023
Revista Brasileira de Ginecologia e Obstetrícia. 2023;45(4):215-219
06-30-2023
Summary
FEBRASGO POSITION STATEMENTAccurate diagnosis of breast lesions Number 4 – April 2023
Revista Brasileira de Ginecologia e Obstetrícia. 2023;45(4):215-219
06-30-2023 -
FEBRASGO POSITION STATEMENT
Abnormal uterine bleeding and chronic iron deficiency: Number 11 – December 2022
Revista Brasileira de Ginecologia e Obstetrícia. 2022;44(12):1161-1168
03-24-2022
Summary
FEBRASGO POSITION STATEMENTAbnormal uterine bleeding and chronic iron deficiency: Number 11 – December 2022
Revista Brasileira de Ginecologia e Obstetrícia. 2022;44(12):1161-1168
03-24-2022 -
FEBRASGO POSITION STATEMENT
Challenges of breast cancer screening: Number 9 – September 2023
Revista Brasileira de Ginecologia e Obstetrícia. 2023;45(9):551-554
00-00-2023
Summary
FEBRASGO POSITION STATEMENTChallenges of breast cancer screening: Number 9 – September 2023
Revista Brasileira de Ginecologia e Obstetrícia. 2023;45(9):551-554
00-00-2023